ScholarIQanswers from OpenAlex

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

PaperCitations, authors & open-access status

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme have?

ScholarIQcitation count

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme has 1,896 citations in the OpenAlex counts ScholarIQ stores.

When was Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme published?

ScholarIQyear

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme has 2003 year in the ScholarIQ index.

What is the open-access status of Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme?

ScholarIQoa status

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme has closed oa status in the ScholarIQ index.

What is the DOI of Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme?

ScholarIQdoi

The DOI for Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme is on the source record.

What is the PMID of Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme?

ScholarIQpmid

The PMID for Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme is on the source record.

What is the OpenAlex record for Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme?

ScholarIQopenalex

The OpenAlex for Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial